Insider · CIK 0001614821
Bhatnagar Anish
ceoofficerdirector
Files at SLNO (SOLENO THERAPEUTICS INC). First filing Jan 6, 2025, latest Mar 31, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $48M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | SOLENO THERAPEUTICS INC | $47M 699,095 shares | -93% | - | |
| 58Moderate | SOLENO THERAPEUTICS INC | $966k 21,091 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | SLNO SOLENO THERAPEUTICS INC | FTax withholding Common Stock | -7,620 | $49.95 | $381k | 569,456 | Dec 17, 2025 |
| Dec 15, 2025 | SLNO SOLENO THERAPEUTICS INC | GGift Common Stock | -100,000 | $0.00 | $0 | 469,456 | Dec 17, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -14,183 | $65.97 | $936k | 738,179 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -23,095 | $66.79 | $1.5M | 715,084 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -41,989 | $67.70 | $2.8M | 673,095 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -55,234 | $68.79 | $3.8M | 617,861 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -31,980 | $69.84 | $2.2M | 585,881 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -3,291 | $70.73 | $233k | 582,590 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -4,782 | $71.74 | $343k | 577,808 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -732 | $72.64 | $53k | 577,076 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +26,606 | $24.00 | $639k | 603,682 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +16,666 | $25.05 | $417k | 620,348 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +105,000 | $33.60 | $3.5M | 725,348 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +32,193 | $5.10 | $164k | 757,541 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +62,291 | $2.41 | $150k | 819,832 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Common Stock | +281,053 | $5.25 | $1.5M | 1,100,885 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -106,471 | $65.81 | $7.0M | 994,414 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -209,689 | $66.33 | $14M | 784,725 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -8,423 | $67.37 | $567k | 776,302 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -199,226 | $69.30 | $14M | 577,076 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -26,606 | $0.00 | $0 | 60 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -16,666 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -105,000 | $0.00 | $0 | 35,000 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -32,193 | $0.00 | $0 | 8,473 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -62,291 | $0.00 | $0 | 52,709 | Mar 31, 2025 |
| Mar 27, 2025 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | -281,053 | $0.00 | $0 | 200,753 | Mar 31, 2025 |
| Jan 21, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +53,900 | $0.00 | $0 | 752,362 | Jan 23, 2025 |
| Jan 21, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Employee stock option (right to buy)derivative | +115,600 | $0.00 | $0 | 115,600 | Jan 23, 2025 |
| Jan 2, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -10,077 | $45.37 | $457k | 709,476 | Jan 6, 2025 |
| Jan 2, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -860 | $45.92 | $39k | 708,616 | Jan 6, 2025 |
| Jan 3, 2025 | SLNO SOLENO THERAPEUTICS INC | SOpen-market sale Common Stock | -10,154 | $46.18 | $469k | 698,462 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.